Today, we announced positive results from the pivotal Phase 3 study of investigational Orca-T versus conventional allogeneic stem cell transplant for the treatment of hematologic malignancies. Results will be presented at the 51st Annual Meeting of the EBMT on April 2, 2025. Read the full announcement here: https://bit.ly/4i8gp1p #celltherapy #oncology #bloodcancer #hematology #EBMT25
Orca Bio
Pharmaceutical Manufacturing
Menlo Park, CA 15,260 followers
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
About us
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. Our investigational products are designed to safely replace a patient’s diseased blood and immune system with a healthy one, delivering better outcomes with fewer risks than the standard of care. Our manufacturing platform uses single-cell precision to create proprietary, uniquely-defined products that have the potential to revolutionize allogeneic cell therapy. Our team of leading scientists, engineers and clinicians is united in our mission to transform the lives of patients. Together, we are working to deliver the promise of a cure, without the compromise. Please note, a member of the Orca Bio team will only ever communicate using an @orcabio.com email address.
- Website
-
http://www.orcabio.com/
External link for Orca Bio
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Menlo Park, CA
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
3475 Edison Way, Suite B
Menlo Park, CA 94025, US
-
3400 Business Dr
140
Sacramento, California 95820, US
Employees at Orca Bio
Updates
-
Scientists, engineers, clinicians, industry professionals. Passion, courage, integrity. These are the people and values that make up #TeamOrcaBio. Today on #EmployeeAppreciationDay, and every day, we are grateful for our team for their commitment to our mission and the patients we are here to serve. Together, we are working to transform the field of allogeneic cell therapy. Thank you for all you do!
-
We are thrilled to announce the appointment of Jesus Varela as Head of People at Orca Bio. Jesus brings over two decades of experience in HR leadership roles supporting biopharma companies through accelerated phases of growth. With Orca Bio, he will be instrumental in scaling our team and culture as we continue to progress toward the commercialization of our investigational high-precision #celltherapies. Welcome to #TeamOrcaBio, Jesus!
-
-
We are excited to be featured in BioSpace’s Biotech Bay Hotbed which showcases companies at the forefront of biotech and life science innovation in the Bay Area. At Orca Bio, our team is committed to advancing cutting-edge cell therapies in our mission to transform treatment solutions for patients. Interested in learning more about #TeamOrcaBio? https://bit.ly/4ifwbXF #celltherapy #biotechbay #oncologyjobs #biotechjobs
The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. Companies like Amgen, BioMarin Pharmaceutical Inc., Sutro Biopharma, Inc. and more are recruiting now. https://hubs.li/Q032tFN10
-
-
Caregivers play a critical role in supporting the health and well-being of those who require assistance due to diseases like cancer, chronic conditions, disabilities, or aging. This #NationalCaregiversDay, we celebrate the ~100 million dedicated individuals who support their loved ones through the patient journey. Explore caregiver resources from the Patient Empowerment Network: https://bit.ly/3CsauVb
-
-
#TeamOrcaBio is on the ground in Honolulu for the 2025 Tandem Meetings of the ASTCTand CIBMTR (Center for International Blood & Marrow Transplant Research). Come check us out at Booth #201! Learn more about the four presentations highlighting our investigational allogeneic T-cell immunotherapies, Orca-T and Orca-Q: https://bit.ly/4hzjRBR #Tandem25 #BloodCancer #CancerResearch #Hematology #Oncology #CellTherapy
-
-
“My advice to young women and girls is this: figure out what you’re passionate about and where your values lie, and look for a career that supports what matters to you.” On International Day of Women and Girls in Science, we recognize and support the vital role that women and girls play in STEM fields. Hear from Orca Bio’s Chief Quality Officer, Lauren Smith, on what #WomenInScience means to her. #IDWGS202 #WomenInSTEM
-
Orca Bio will present results from the pivotal Phase 3 Precision-T study of its investigational allogeneic T-cell immunotherapy, Orca-T, in people with hematologic malignancies at the 51st Annual Meeting of The EBMT in Florence, Italy. The Precision-T study met its primary endpoint of an improvement in survival free of moderate-to-severe chronic graft versus host disease (cGvHD) with Orca-T vs. conventional alloHSCT. More details: https://bit.ly/3CxYku9 #EBMT25 #bloodcancer #celltherapy #oncology #hematology
-
Each year, approximately 1.24 million blood cancer cases occur worldwide. This #WorldCancerDay, we unite to raise awareness and spur action toward reducing the global impact of this deadly disease. For information and resources for patients, caregivers and providers, visit The Leukemia & Lymphoma Society Community: https://bit.ly/4hrLKeu #patientsfirst #unitedbyunique #bloodcancer #cancerresearch #hematology #oncology #celltherapy
-
-
#ICYMI: In a recent Labiotech.eu Beyond Biotech Podcast episode, Orca Bio CEO and co-founder, Ivan Dimov, sat down to recap #JPM25. Tune into the latest episode to hear more on the biggest trends and highlights emerging from this year’s annual conference: https://lnkd.in/dhVv_FgD #BeyondBiotechPodcast #bloodcancer #oncology #hematology #celltherapy #biotech
Did you manage to catch JPM last week? 📅 If you didn’t, worry not! 😌 Our latest podcast episode delves into the major highlights of the event. 🔊 📢 While there weren’t necessarily many financial blockbusters, there were plenty of announcements on everything from artificial intelligence and the rising influence of Chinese companies, to the potential ramifications of the Trump administration in the U.S. 🇺🇸 We were in conversation with Orca Bio’s CEO Ivan Dimov and Parabilis Medicines’ CBO Gregory Miller to bring you all the trends you may have missed. 📈 🎧 Tune in to find out more! 👇 https://lnkd.in/dhVv_FgD #BeyondBiotechPodcast #biotechhighlights #biotechtrends #healthcareinnovation #lifesciences #industryinsights #globalbiotech